SG11202103984WA - PPARd activator - Google Patents
PPARd activatorInfo
- Publication number
- SG11202103984WA SG11202103984WA SG11202103984WA SG11202103984WA SG11202103984WA SG 11202103984W A SG11202103984W A SG 11202103984WA SG 11202103984W A SG11202103984W A SG 11202103984WA SG 11202103984W A SG11202103984W A SG 11202103984WA SG 11202103984W A SG11202103984W A SG 11202103984WA
- Authority
- SG
- Singapore
- Prior art keywords
- ppard
- activator
- ppard activator
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018199523 | 2018-10-23 | ||
PCT/JP2019/041563 WO2020085393A1 (en) | 2018-10-23 | 2019-10-23 | PPARδ ACTIVATOR |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202103984WA true SG11202103984WA (en) | 2021-05-28 |
Family
ID=70332034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202103984WA SG11202103984WA (en) | 2018-10-23 | 2019-10-23 | PPARd activator |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220031666A1 (en) |
EP (1) | EP3871667A4 (en) |
JP (2) | JP7397491B2 (en) |
CN (1) | CN112912069A (en) |
SG (1) | SG11202103984WA (en) |
WO (1) | WO2020085393A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
CA2484306A1 (en) | 2002-04-26 | 2003-11-06 | Katsumi Maezono | Prophylactic and therapeutic agent of diabetes mellitus |
AU2007341981A1 (en) * | 2006-12-29 | 2008-07-10 | The Salk Institute For Biological Studies | Methods for enhancing exercise performance |
WO2009086526A2 (en) | 2007-12-28 | 2009-07-09 | The Salk Institute For Biological Studies | Methods for enhancing muscle performance and tone |
CA3036587A1 (en) | 2016-10-05 | 2018-04-12 | Mitobridge, Inc. | Crystalline and salt forms of ppar agonist compounds |
JP6884380B2 (en) | 2017-05-29 | 2021-06-09 | 株式会社寺岡精工 | Packaging equipment |
-
2019
- 2019-10-23 US US17/286,904 patent/US20220031666A1/en active Pending
- 2019-10-23 EP EP19875990.4A patent/EP3871667A4/en active Pending
- 2019-10-23 SG SG11202103984WA patent/SG11202103984WA/en unknown
- 2019-10-23 WO PCT/JP2019/041563 patent/WO2020085393A1/en unknown
- 2019-10-23 CN CN201980069412.1A patent/CN112912069A/en active Pending
- 2019-10-23 JP JP2020553434A patent/JP7397491B2/en active Active
-
2023
- 2023-09-14 JP JP2023149458A patent/JP2023165025A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7397491B2 (en) | 2023-12-13 |
WO2020085393A1 (en) | 2020-04-30 |
JPWO2020085393A1 (en) | 2021-09-09 |
US20220031666A1 (en) | 2022-02-03 |
EP3871667A4 (en) | 2022-08-17 |
CN112912069A (en) | 2021-06-04 |
EP3871667A1 (en) | 2021-09-01 |
JP2023165025A (en) | 2023-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3793565T3 (en) | Mcl-1-inhibitorer | |
DK3467457T3 (en) | Vibrationssensor | |
DK3759096T3 (en) | Cd73-inhibitorer | |
CA185383S (en) | Casque | |
CA185382S (en) | Casque | |
CA185384S (en) | Casque | |
GB201803568D0 (en) | Novel compounds and uses | |
CA185385S (en) | Casque | |
DK3773537T3 (en) | Stat3-hæmmere | |
DK3554057T3 (en) | Audioheadsetsystem | |
DK3768830T3 (en) | Cancerterapi | |
DK3613739T3 (en) | Integrin-antagonister | |
DK3753395T3 (en) | Indvendigt luftstyringssystem | |
DK3872428T3 (en) | Indvendigt luftstyringssystem | |
CA184991S (en) | Uroflowmeter | |
DK3633783T3 (en) | Universal-powerbank | |
CA184994S (en) | Uroflowmeter | |
GB201812078D0 (en) | Novel compounds and their uses | |
EP3766087C0 (en) | Sensformer | |
EP3841303C0 (en) | Microblower | |
DK3768906T3 (en) | Træmodul | |
DK3674425T3 (en) | Stålwire | |
DK3650069T3 (en) | Trakeostomiventil | |
GB201801102D0 (en) | New compounds and uses | |
DK3570498T3 (en) | Adaptivt hvac-styresystem |